Medindia

X

DRL to Sell Generic Version of Montelukast Sodium in US

by Kathy Jones on  September 28, 2012 at 7:41 PM Drug News   - G J E 4
Hyderabad based pharmaceutical company Dr Reddy's Laboratories has announced that it has launched the generic version of its Montelukast Sodium oral granules in the United States after receiving approval from the US Food and Drug Administration.
 DRL to Sell Generic Version of Montelukast Sodium in US
DRL to Sell Generic Version of Montelukast Sodium in US
Advertisement

The granules are a bioequivalent generic version of Singulair and will be used in treating asthma and other seasonal allergies.

Advertisement
The company said that the granules will be available in 4mg strengths and will come in a pack of 30. Figures from IMS Health shows that Singulair oral granules accounted for annual sales of $61 million in the US market.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: